^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NGC-capecitabine (PCS6422)

    i
    Other names: PCS6422, ADH300004, NGC-Cap
    Associations
    News
    Trials
    Company:
    Elion Oncology, Processa Pharma
    Drug class:
    DPYD inhibitor
    Related drugs:
    Associations
    News
    Trials